Kamada Awarded European Orphan Drug Designation for its Alpha-1 Antitrypsin to Treat Graft-versus-Host Disease
Kamada Awarded European Orphan Drug Designation for its Alpha-1 Antitrypsin to Treat Graft-versus-Host Disease
Kamada Awarded European Orphan Drug Designation for its Alpha-1 Antitrypsin to Treat Graft-versus-Host Disease